HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Schiff base derivative for effective treatment of diethylnitrosamine-induced liver cancer in vivo.

Abstract
Hepatocellular carcinoma is one of the most prevalent cancers, with a high morbidity rate, even in developed countries. In the present study, the curative effect of the Schiff base (SB) heterodinuclear copper(II)Mn(II) complex on diethylnitrosamine (DEN)-induced liver carcinoma was investigated. Hepatocarcinoma was initiated by an injection of DEN and promoted by phenobarbital (0.05%) in the diet. In addition, the potential nephrotoxicity of SB was evaluated in a cisplatin-induced nephrotoxicity model. Rats were administered the SB complex (1 and 2 mg/kg body weight/day) for 24 weeks, and cancer progression was investigated by macroscopic, histopathological, and western blot examinations. The administration of SB decreased the incidence and the number of hepatic nodules in a dose-dependent manner by regulating inflammation response and the apoptotic pathway. Western blot analyses from the livers of rats treated with SB after DEN induction showed significantly enhanced Bax and caspase-3 levels, with a marked decrease in the levels of Bcl-2, NF-κB p65 and cyclooxygenase (COX)-2. Results from the nephrotoxicity study showed that, whereas cisplatin increased serum urea nitrogen and creatinine levels, no increase in serum biochemical parameters was detected in SB-treated animals. Moreover, protein levels of NF-E2-related factor-2 (Nrf2) and heme oxygenase-1 were lower, whereas nuclear factor-κB (NF-κB p65) and activator protein-1 levels were higher in the kidneys of cisplatin-treated animals compared with that of the SB groups. Therefore, the SB complex could be an alternative chemotherapeutic option for liver cancer treatment once its safety in clinical applications has been examined.
AuthorsSelami Demirci, Ayşegül Doğan, Neşe Başak, Dilek Telci, Bülent Dede, Cemal Orhan, Mehmet Tuzcu, Kazm Şahin, Nurhan Şahin, İbrahim Hanifi Özercan, Fikrettin Şahin
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 26 Issue 5 Pg. 555-64 (Jun 2015) ISSN: 1473-5741 [Electronic] England
PMID25714251 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Coordination Complexes
  • Schiff Bases
  • Diethylnitrosamine
  • Manganese
  • Copper
  • Cisplatin
Topics
  • Animals
  • Antineoplastic Agents (chemistry, therapeutic use, toxicity)
  • Apoptosis (drug effects)
  • Cisplatin (toxicity)
  • Coordination Complexes (chemistry, therapeutic use, toxicity)
  • Copper
  • Diethylnitrosamine
  • Kidney (drug effects, pathology)
  • Kidney Diseases (chemically induced, pathology)
  • Liver (drug effects, pathology)
  • Liver Neoplasms (chemically induced, drug therapy, pathology)
  • Manganese
  • Rats, Wistar
  • Schiff Bases (chemistry, therapeutic use, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: